Ninlaro

2 newer multiple myeloma drugs fall short in bid for wider market
BioPharma Dive
Tue, 03/10/20 - 11:58 am
Multiple Myeloma
clinical trials
Bristol-Myers Squibb
Takeda
Ninlaro
Empliciti
Revlimid
Takeda scores a win for Ninlaro as it aims to pioneer 'switch' maintenance in multiple myeloma
Fierce Pharma
Fri, 11/8/19 - 10:57 am
Takeda
Ninlaro
Multiple Myeloma
clinical trials
Takeda suffers another setback in its quest to expand myeloma drug’s reach — and blockbuster potential
Endpoints
Thu, 06/6/19 - 12:08 pm
Takeda
Ninlaro
clinical trials
ASH: Takeda maintenance data sets up Ninlaro for new myeloma nod
Fierce Pharma
Sun, 12/2/18 - 12:34 pm
ASH2018
Takeda
Ninlaro
Multiple Myeloma
Takeda's Ninlaro Met Primary Endpoint in Ph III Trial In Patients with Multiple Myeloma Post Stem Cell Transplant
CP Wire
Wed, 07/11/18 - 10:15 am
Takeda
Ninlaro
Multiple Myeloma
Takeda's Ninlaro Met Primary Endpoint in Ph III Trial In Patients with Multiple Myeloma Post Stem Cell Transplant
Wed, 07/11/18 - 09:56 am
Ninlaro
Takeda Pharmaceuticals
Multiple Myeloma
Takeda starts work on €40M plant to produce multiple myeloma drug Ninlaro
Fierce Pharma
Wed, 06/7/17 - 12:10 pm
Takeda
drug manufacturing
Multiple Myeloma
Ninlaro
How Takeda Is Changing The Face Of Myeloma Treatment
Seeking Alpha
Sat, 05/7/16 - 01:19 pm
Takeda
Multiple Myeloma
Ninlaro
Amgen's Kyprolis stands its ground against new J&J, BMS rivals
Fierce Pharma
Wed, 05/4/16 - 09:48 am
Amgen
Kyprolis
JNJ
Bristol-Myers Squibb
Multiple Myeloma
Darzalex
Empliciti
AbbVie
Takeda
Ninlaro
New myeloma meds work better than the old, but they're far too expensive: Report
Fierce Biotech
Tue, 04/12/16 - 03:39 pm
Multiple Myeloma
Bristol-Myers Squibb
Amgen
Takeda
Empliciti
Kyprolis
Ninlaro
Celgene
Revlimid
FDA approves 3rd multiple myeloma med of 2015, Takeda's Ninlaro
BioPharma Dive
Mon, 11/23/15 - 01:19 pm
FDA
Takeda
Ninlaro
Multiple Myeloma